Literature DB >> 12208759

Enhanced induction of telomerase-specific CD4(+) T cells using dendritic cells transfected with RNA encoding a chimeric gene product.

Zhen Su1, Johannes Vieweg, Alon Z Weizer, Philipp Dahm, Donna Yancey, Vandana Turaga, John Higgins, David Boczkowski, Eli Gilboa, Jens Dannull.   

Abstract

Dendritic cells (DCs) transfected with mRNA encoding human telomerase reverse transcriptase (hTERT) have been shown to represent potent inducers of CTLs and antitumor immunity. However, it has become widely accepted that not only CTLs but also CD4(+) T helper cells are critical to the generation, as well as to the maintenance, of potent antitumor responses in vivo. In this study, we sought to determine whether human DCs transfected with mRNA encoding a chimeric hTERT/lysosome-associated membrane protein (LAMP-1) protein, carrying the endosomal/lysosomal sorting signal of the LAMP-1, are capable of stimulating concomitant hTERT-specific CD8(+) and CD4(+) T-cell responses in vitro. We show that processing of hTERT/LAMP-1 transcripts leads to enhanced stimulation of hTERT-specific CD4(+) T cells and does not negatively affect intracellular generation and subsequent presentation of MHC class I epitopes, hence, generating a CTL response. These findings provide a preclinical rationale of using DCs transfected with the chimeric hTERT/LAMP-1 RNA in vaccine trials to facilitate generation of antigen-specific CD4(+) T-cell responses that may be required to stimulate and maintain an optimal CD8(+) CTL response in vivo.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12208759

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  24 in total

1.  Cytoplasmic expression of EGFP in dendritic cells transfected with in vitro transcribed mRNA or cellular total RNA extracted from EGFP expressing leukemia cells.

Authors:  Masuhiro Takahashi; Miwako Narita; Flavio Ayres; Naoko Satoh; Takashi Abe; Toshio Yanao; Tatsuo Furukawa; Ken Toba; Takeshi Hirohashi; Yoshifusa Aizawa
Journal:  Med Oncol       Date:  2003       Impact factor: 3.064

Review 2.  Modulation of antitumor responses by dendritic cells.

Authors:  Johannes Vieweg; Andrew Jackson
Journal:  Springer Semin Immunopathol       Date:  2005-01

3.  Expansion of HIV-specific CD4+ and CD8+ T cells by dendritic cells transfected with mRNA encoding cytoplasm- or lysosome-targeted Nef.

Authors:  Daniel G Kavanagh; Daniel E Kaufmann; Sherzana Sunderji; Nicole Frahm; Sylvie Le Gall; David Boczkowski; Eric S Rosenberg; David R Stone; Mary N Johnston; Bradford S Wagner; Mohammad T Zaman; Christian Brander; Eli Gilboa; Bruce D Walker; Nina Bhardwaj
Journal:  Blood       Date:  2005-10-25       Impact factor: 22.113

4.  Tumor-associated antigen-based personalized dendritic cell vaccine in solid tumor patients.

Authors:  Qian-Ting Wang; Ying Nie; Sheng-Nan Sun; Tao Lin; Ru-Jin Han; Jun Jiang; Zhe Li; Jun-Qi Li; Yun-Peng Xiao; Yu-Ying Fan; Xiao-Hui Yuan; Hui Zhang; Bin-Bin Zhao; Ming Zeng; Shi-You Li; Hua-Xin Liao; Jian Zhang; You-Wen He
Journal:  Cancer Immunol Immunother       Date:  2020-02-20       Impact factor: 6.968

Review 5.  A second chance for telomerase reverse transcriptase in anticancer immunotherapy.

Authors:  Maurizio Zanetti
Journal:  Nat Rev Clin Oncol       Date:  2016-06-01       Impact factor: 66.675

6.  Both antigen optimization and lysosomal targeting are required for enhanced anti-tumour protective immunity in a human papillomavirus E7-expressing animal tumour model.

Authors:  Mi Suk Kim; Jeong-Im Sin
Journal:  Immunology       Date:  2005-10       Impact factor: 7.397

Review 7.  Engineering dendritic cells to enhance cancer immunotherapy.

Authors:  Jeanette E Boudreau; Aude Bonehill; Kris Thielemans; Yonghong Wan
Journal:  Mol Ther       Date:  2011-04-05       Impact factor: 11.454

Review 8.  Prospects and challenges of building a cancer vaccine targeting telomerase.

Authors:  Robert H Vonderheide
Journal:  Biochimie       Date:  2007-07-17       Impact factor: 4.079

Review 9.  Cancer immunotherapy using RNA-loaded dendritic cells.

Authors:  P Ponsaerts; V F I Van Tendeloo; Z N Berneman
Journal:  Clin Exp Immunol       Date:  2003-12       Impact factor: 4.330

10.  DNA vaccine encoding human immunodeficiency virus-1 Gag, targeted to the major histocompatibility complex II compartment by lysosomal-associated membrane protein, elicits enhanced long-term memory response.

Authors:  Luciana Barros de Arruda; Priya R Chikhlikar; J Thomas August; Ernesto T A Marques
Journal:  Immunology       Date:  2004-05       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.